Dr. Nicholas M. Cardiges, MD

Dr. Cardiges practices at Allentown Campus - Interventional Radiology Unit - HOPD in Allentown, Pennsylvania.

Dr. Cardiges' NPI, 1831142124, was assigned on May 18, 2006. Dr. Cardiges graduated from University of Maryland School of Medicine - Baltimore in 1990. Dr. Cardiges holds Pennsylvania license MD055970L.

Dr. Cardiges' primary practice is Allentown Campus - Interventional Radiology Unit - HOPD, at 1736 Hamilton St, Allentown, PA 18104.

Dr. Cardiges' primary practice is Allentown Campus - Interventional Radiology Unit - HOPD in Allentown, Pennsylvania. Dr. Cardiges is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Cardiges to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cardiges practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Cardiges' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Cardiges is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Cardiges' licenses on file in 2 states: Pennsylvania and New Jersey.

Dmand AI lists bone cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Cardiges treats.

CMS data shows 3,115 Medicare services from Dr. Cardiges across 16 procedure codes in 2024, for 346 Medicare patients. Medicare paid $203,687 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 346 Medicare patients who saw Dr. Cardiges in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cardiges' median patient age at 74, with 38% women.

In 2024, Dr. Cardiges wrote 82 Medicare Part D claims for 32 patients. 99% of them were for generic drugs. CMS names the drug for 45 of them, across 1 drug with 11 or more claims each, at $505 in total drug cost. In 2023, CMS named 64 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Cardiges for performance year 2024, reported through an alternative payment model (APM). Dr. Cardiges accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Cardiges.

CMS Open Payments shows 73 general payments to Dr. Cardiges from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Siemens Medical Solutions USA, Inc. paid the most, $1,017.

Dr. Cardiges graduated from University of Maryland School of Medicine - Baltimore in 1990.

Dr. Cardiges is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Highmark. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.